367 related articles for article (PubMed ID: 19724783)
1. Immunotherapy for cancer: synthetic carbohydrate-based vaccines.
Buskas T; Thompson P; Boons GJ
Chem Commun (Camb); 2009 Sep; (36):5335-49. PubMed ID: 19724783
[TBL] [Abstract][Full Text] [Related]
2. Recent development in carbohydrate-based cancer vaccines.
Guo Z; Wang Q
Curr Opin Chem Biol; 2009 Dec; 13(5-6):608-17. PubMed ID: 19766052
[TBL] [Abstract][Full Text] [Related]
3. A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinic.
Wilson RM; Danishefsky SJ
J Am Chem Soc; 2013 Oct; 135(39):14462-72. PubMed ID: 23944352
[TBL] [Abstract][Full Text] [Related]
4. Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.
Zhu J; Warren JD; Danishefsky SJ
Expert Rev Vaccines; 2009 Oct; 8(10):1399-413. PubMed ID: 19803761
[TBL] [Abstract][Full Text] [Related]
5. Synthetic glycopeptides for the development of cancer vaccines.
Liakatos A; Kunz H
Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
[TBL] [Abstract][Full Text] [Related]
6. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
[TBL] [Abstract][Full Text] [Related]
7. Fully synthetic self-adjuvanting thioether-conjugated glycopeptide-lipopeptide antitumor vaccines for the induction of complement-dependent cytotoxicity against tumor cells.
Cai H; Sun ZY; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2013 Feb; 19(6):1962-70. PubMed ID: 23280874
[TBL] [Abstract][Full Text] [Related]
8. Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.
Keding SJ; Danishefsky SJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11937-42. PubMed ID: 15280546
[TBL] [Abstract][Full Text] [Related]
9. [Recent advance in carbohydrate-based cancer vaccines].
Huo CX; Ye XS
Yao Xue Xue Bao; 2012 Mar; 47(3):261-70. PubMed ID: 22645748
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization.
Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ
J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973
[TBL] [Abstract][Full Text] [Related]
11. Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.
Pifferi C; Thomas B; Goyard D; Berthet N; Renaudet O
Chemistry; 2017 Nov; 23(64):16283-16296. PubMed ID: 28845889
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-based cancer vaccines: target cancer with sugar bullets.
Liu CC; Ye XS
Glycoconj J; 2012 Aug; 29(5-6):259-71. PubMed ID: 22669462
[TBL] [Abstract][Full Text] [Related]
14. Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities.
Ouerfelli O; Warren JD; Wilson RM; Danishefsky SJ
Expert Rev Vaccines; 2005 Oct; 4(5):677-85. PubMed ID: 16221069
[TBL] [Abstract][Full Text] [Related]
15. Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors.
Ingale S; Wolfert MA; Buskas T; Boons GJ
Chembiochem; 2009 Feb; 10(3):455-63. PubMed ID: 19145607
[TBL] [Abstract][Full Text] [Related]
16. A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response.
Dziadek S; Hobel A; Schmitt E; Kunz H
Angew Chem Int Ed Engl; 2005 Nov; 44(46):7630-5. PubMed ID: 16247815
[No Abstract] [Full Text] [Related]
17. Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue.
Hoffmann-Röder A; Kaiser A; Wagner S; Gaidzik N; Kowalczyk D; Westerlind U; Gerlitzki B; Schmitt E; Kunz H
Angew Chem Int Ed Engl; 2010 Nov; 49(45):8498-503. PubMed ID: 20878823
[No Abstract] [Full Text] [Related]
18. Synthesis and vaccine evaluation of the tumor-associated carbohydrate antigen RM2 from prostate cancer.
Chuang HY; Ren CT; Chao CA; Wu CY; Shivatare SS; Cheng TJ; Wu CY; Wong CH
J Am Chem Soc; 2013 Jul; 135(30):11140-50. PubMed ID: 23819648
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate vaccines as immunotherapy for cancer.
Slovin SF; Keding SJ; Ragupathi G
Immunol Cell Biol; 2005 Aug; 83(4):418-28. PubMed ID: 16033538
[TBL] [Abstract][Full Text] [Related]
20. From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.
Zhu J; Wan Q; Lee D; Yang G; Spassova MK; Ouerfelli O; Ragupathi G; Damani P; Livingston PO; Danishefsky SJ
J Am Chem Soc; 2009 Jul; 131(26):9298-303. PubMed ID: 19518111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
